Catalyst Wire Dossier Catalyst Wire Dossier

Prandial INSULIN-PH20 NP

· Halozyme Therapeutics
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Prandial INSULIN-PH20 NP, covering 2014-09-08 to 2014-09-08. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of Subcutaneously-Injected Prandial INSULIN-PH20 NP Compared to Insulin Lispro Injection in Participants With Type 1 Diabetes Mellitus [Phase 2]

See pricing